The Foundation of our Analyses

The “Disease Target Assessment” (DTA) model, which is the go-to tool for our clients, acts as the foundation of all of our forecast models. The DTA model aims to quantify the level of unmet medical need in a given indication under the current standard of care. Emerging agents are measured against this benchmark based on the reduction in unmet medical need that they offer. This methodology is adapted and expanded upon in order to fit each client’s unique needs in disease-are strategy, business development, early R&D, late-stage development, and beyond. The primary output of the DTA is an assets projected peak-year patient share.